These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 12474879

  • 1. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Dec 02; 67(235):72555-9. PubMed ID: 12474879
    [Abstract] [Full Text] [Related]

  • 2. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for combination drug products. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Dec 23; 67(246):78158-72. PubMed ID: 12508820
    [Abstract] [Full Text] [Related]

  • 3. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 04; 68(107):33362-81. PubMed ID: 12785379
    [Abstract] [Full Text] [Related]

  • 4. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May 21; 64(98):27666-93. PubMed ID: 10558542
    [Abstract] [Full Text] [Related]

  • 5. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Sep 27; 66(188):49276-8. PubMed ID: 11758596
    [Abstract] [Full Text] [Related]

  • 6. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug 01; 65(148):46864-8. PubMed ID: 11067707
    [Abstract] [Full Text] [Related]

  • 7. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 31; 68(250):75414-8. PubMed ID: 14986677
    [Abstract] [Full Text] [Related]

  • 8. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 09; 68(110):34273-93. PubMed ID: 12795305
    [Abstract] [Full Text] [Related]

  • 9. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 17; 68(74):18861-9. PubMed ID: 12701599
    [Abstract] [Full Text] [Related]

  • 10. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Nov 30; 72(230):67639-40. PubMed ID: 18064767
    [Abstract] [Full Text] [Related]

  • 11. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2011 Jul 26; 76(143):44475-89. PubMed ID: 21796845
    [Abstract] [Full Text] [Related]

  • 12. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 17; 68(74):18869-82. PubMed ID: 12701600
    [Abstract] [Full Text] [Related]

  • 13. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Apr 29; 74(81):19385-409. PubMed ID: 19507324
    [Abstract] [Full Text] [Related]

  • 14. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 13; 68(114):35290-3. PubMed ID: 12807133
    [Abstract] [Full Text] [Related]

  • 15. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Mar 24; 69(57):13725-35. PubMed ID: 15040351
    [Abstract] [Full Text] [Related]

  • 16. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 19; 72(243):71769-85. PubMed ID: 18159651
    [Abstract] [Full Text] [Related]

  • 17. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 May 09; 67(90):31123-5. PubMed ID: 12001971
    [Abstract] [Full Text] [Related]

  • 18. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
    Fed Regist; 1998 Apr 22; 63(77):19799-802. PubMed ID: 10179316
    [Abstract] [Full Text] [Related]

  • 19. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar 17; 64(51):13254-303. PubMed ID: 10557606
    [Abstract] [Full Text] [Related]

  • 20. Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS.
    Fed Regist; 1999 Mar 17; 64(51):13066-7. PubMed ID: 10557605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.